Healthtech Startups

Behavidence Enterprise is a clinical decision support platform that uses digital biomarkers to help healthcare professionals make diagnostic and treatment decisions.

5 investors

Beren is a public benefit corporation developing novel medicines in partnership with patients, caregivers, clinicians, and health systems. It focuses on advancing biology and chemistry to address the root causes of diseases.

5 investors

Berry Street provides credentialing, billing, administrative, and referral support to independent dietitians, enabling them to accept insurance and serve patients seeking nutrition therapy. The platform connects dietitians with patients who want personalized nutrition care regardless of ability to pay.

5 investors

Biodock provides an AI image analysis platform designed for researchers and scientists to train, run, and interpret deep learning models on biological images without requiring coding expertise. The platform enables rapid model creation, distributed execution at scale, and detailed quantitative analysis for research organizations in biotech and life sciences.

5 investors

BioReact provides a data integration platform that unifies experimental data from bioreactors, laboratory instruments, and omics workflows into a standardized, AI-ready format for bioprocess development. The platform serves scientists in synthetic biology, cell therapy, biologics, and precision fermentation who need to consolidate fragmented scientific data for analytics and machine learning.

5 investors

Biosapien develops treatments for cancer that are delivered locally to shrink tumors, relieve symptoms, and reduce the need for surgeries.

5 investors

Biospatial operates a data analytics platform that ingests emergency medical services (EMS) and health data to deliver real-time analytics and insights for healthcare and public health users. The company applies machine learning, anomaly detection, and multi-source data analytics to support clinical and biosurveillance workflows.

5 investors

BioStack provides a platform for bioinformatics and experimental science that integrates biological insights with computational technology. The platform serves researchers and scientists working in modern biology and life sciences research.

5 investors

Blooming Health operates a care enablement platform that uses AI-assisted co-pilots to detect unmet social needs, close clinical gaps, and guide members through preventive screenings, wellness visits, and benefits renewals such as Medicaid and SNAP. It serves health systems, health plans, and government agencies across 25 U.S. states, supporting community engagement in more than 55 languages.

5 investors

Bluenote provides an AI platform for life sciences companies that automates the drafting of scientific and regulatory documents, workflow automation, and internal data search to speed up regulatory submissions. It serves pharmaceutical, medical device, diagnostics, CRO, and CDMO organizations across the product lifecycle, from pre-clinical and clinical to CMC, regulatory, quality, and commercial stages.

5 investors

Boundless (Thrive) offers a personalized digital health app that helps users adopt small daily behavior changes across five areas — food, movement, sleep, stress management, and social connection — through baseline assessments and tailored daily guidance. It applies behavioral science to improve health outcomes and help people manage chronic conditions.

5 investors

BrainKey develops artificial intelligence and medical imaging analysis tools for neuroimaging data interpretation. The company serves physicians and patients by making brain anatomy measurable, visible, and more interpretable through advanced analytical software.

5 investors

Miist develops inhaled microparticle therapeutics that deliver medicine to the bloodstream in 30 seconds, targeting conditions like migraine, pain, and anxiety where rapid onset is critical. The company is advancing a portfolio of systemic therapies starting with MST-02, a migraine treatment designed to work significantly faster than existing oral medications.

5 investors

b.well, founded after the CEO's personal experience navigating fragmented health data, builds technology to aggregate and analyze an individual's health information across sources. The company focuses on consumer healthcare, with an emphasis on serving underserved populations.

5 investors

C. Light Technologies develops eye-tracking technology for clinical applications, offering objective metrics to assess patient neurological and vision-related conditions. The company's FDA-approved Retitrack device detects fixational eye movements for use in diagnosing neurodegenerative diseases, brain injuries, and sports vision performance.

5 investors

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy. The medical device is designed to be adaptable to individual patient needs and was developed in collaboration with Mayo Clinic.

5 investors

CCG.ai develops software that uses clinical and genomic data to help oncologists select appropriate cancer treatments for individual patients, with a focus on identifying predictive biomarkers linked to treatment response.

5 investors

Canopy develops an IoT-based wearable safety platform for healthcare organizations to protect workers from safety risks and workplace violence. The company delivers a comprehensive connected safety solution serving hospitals and healthcare systems across the United States.

5 investors

Judi Rx (formerly Capital Rx) is a transparent, fiduciary-aligned pharmacy benefits manager that prices drugs against the federal NADAC benchmark, passes through rebates, and charges a single flat administrative fee. It serves employers, labor unions, health plans, and brokers, and runs on the cloud-based Judi platform alongside Judi Care for unified pharmacy and medical benefits administration.

5 investors

AbbVie is a biopharmaceutical company that discovers and delivers medicines for immune-mediated diseases and other therapeutic areas globally.

5 investors

5 investors

Caraway Therapeutics was a preclinical biopharmaceutical company developing small-molecule therapies modulating lysosomal function to treat neurodegenerative and rare diseases. Acquired by Merck in 2023.

5 investors

CarePort provides care coordination workflow tools and services for hospital associations and Health Information Exchanges (HIEs) to help their member organizations address patient safety, readmission reduction, and patient engagement. The company operates a nationwide care coordination network serving healthcare providers across the risk continuum.

5 investors

CareRev operates a platform connecting healthcare facilities with nursing professionals to address medical staffing challenges. The company builds tools for healthcare systems and clinicians to manage workforce flexibility and efficiency.

5 investors